Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PI3K/AKT/MTOR PATHWAY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Name | PI3K/AKT/MTOR PATHWAY |
Knowledge base pages for this entity
graph TD
PI3K_AKT_MTOR_PATHWAY["PI3K/AKT/MTOR PATHWAY"]
PI3K_AKT_MTOR_PATHWAY -->|"involved_in"| Cancer["Cancer"]
PI3K_AKT_MTOR_PATHWAY -->|"contributes to"| Hormone_Receptor_Positive_Adva["Hormone Receptor-Positive Advanced Breast Cancer"]
PI3K_AKT_MTOR_PATHWAY -->|"involved_in"| Breast_Cancer["Breast Cancer"]
PI3K_AKT_MTOR_PATHWAY -->|"promotes"| Tumor_Growth["Tumor Growth"]
PI3K_AKT_MTOR_PATHWAY -->|"mediates"| Endocrine_Therapy_Resistance["Endocrine Therapy Resistance"]
PI3K_AKT_MTOR_PATHWAY -->|"mediates"| Cdk4_6_Inhibitor_Resistance["Cdk4/6 Inhibitor Resistance"]
PI3K_AKT_MTOR_PATHWAY -->|"promotes"| cell_survival["cell survival"]
PI3K_AKT_MTOR_PATHWAY -->|"promotes"| dystrophic_neurites["dystrophic neurites"]
Piperine["Piperine"] -->|"activates"| PI3K_AKT_MTOR_PATHWAY
PIK3CA["PIK3CA"] -->|"involved_in"| PI3K_AKT_MTOR_PATHWAY
CHRYSOTOXINE["CHRYSOTOXINE"] -->|"inhibits"| PI3K_AKT_MTOR_PATHWAY
Capivasertib["Capivasertib"] -->|"inhibits"| PI3K_AKT_MTOR_PATHWAY
Alpelisib["Alpelisib"] -->|"inhibits"| PI3K_AKT_MTOR_PATHWAY
MARCKS["MARCKS"] -->|"activates"| PI3K_AKT_MTOR_PATHWAY
insulin_resistance["insulin resistance"] -->|"inhibits"| PI3K_AKT_MTOR_PATHWAY
STX11["STX11"] -->|"inhibits"| PI3K_AKT_MTOR_PATHWAY| Target | Relation | Type | Str |
|---|---|---|---|
| Hormone Receptor-Positive Advanced Breast Cancer | contributes_to | disease | 0.95 |
| Tumor Growth | promotes | process | 0.95 |
| Colorectal Cancer Initiation | involved_in | process | 0.95 |
| Colorectal Cancer Progression | involved_in | process | 0.95 |
| Colorectal Cancer Metastasis | promotes | process | 0.95 |
| Breast Tumorigenesis | involved_in | process | 0.95 |
| Cancer | involved_in | disease | 0.95 |
| Breast Cancer | involved_in | disease | 0.95 |
| Insulin Resistance | regulates | phenotype | 0.95 |
| Endocrine Therapy Resistance | mediates | mechanism | 0.93 |
| Cdk4/6 Inhibitor Resistance | mediates | mechanism | 0.93 |
| cell survival | promotes | process | 0.92 |
| dystrophic neurites | promotes | phenotype | 0.92 |
| insulin resistance | causes | phenotype | 0.90 |
| macrophage activation | regulates | phenotype | 0.90 |
| Transcriptional Targets | regulates | process | 0.90 |
| Gene Transcription | regulates | process | 0.90 |
| Tumor Growth | involved_in | process | 0.90 |
| protein turnover | regulates | process | 0.90 |
| cytoskeleton dynamics | regulates | process | 0.90 |
| lipid transport | regulates | process | 0.90 |
| axonal pathology | therapeutic_target | phenotype | 0.90 |
| Breast cancer | implicated_in | disease | 0.90 |
| Colorectal cancer | implicated_in | disease | 0.90 |
| Triple-negative breast cancer | implicated_in | disease | 0.90 |
| Endocrine Resistance | mediates | mechanism | 0.90 |
| Poor Prognosis | associated_with | phenotype | 0.90 |
| Pancreatic Ductal Adenocarcinoma | involved_in | disease | 0.90 |
| Cancer Progression | regulates | disease | 0.90 |
| Autophagy | mediates | process | 0.90 |
| Autophagy | mediates | process | 0.90 |
| Drug Resistance | mediates | phenotype | 0.90 |
| Sjogren's Syndrome | involved_in | disease | 0.85 |
| Tumor Invasion | involved_in | process | 0.85 |
| Idiopathic Pulmonary Fibrosis | involved_in | disease | 0.85 |
| Protein Turnover | regulates | process | 0.85 |
| Cytoskeleton Dynamics | regulates | process | 0.85 |
| Lipid Transport | regulates | process | 0.85 |
| Hormone-Receptor-Positive Breast Cancer | contributes_to | disease | 0.85 |
| Cancer Hallmarks | regulates | process | 0.85 |
| Cellular Growth | modulates | process | 0.85 |
| Cell Proliferation | regulates | process | 0.85 |
| Bladder Cancer | drives | disease | 0.85 |
| Apoptosis | regulates | process | 0.85 |
| Autophagy | regulates | process | 0.85 |
| Tumor Metastasis | associated_with | process | 0.83 |
| endocrine resistance | causes | phenotype | 0.80 |
| insulin resistance | protects_against | phenotype | 0.80 |
| Salivary Gland Damage | involved_in | phenotype | 0.80 |
| Cell Death | modulates | process | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Glioblastoma Multiforme | associated_with | disease | 0.95 |
| Piperine | activates | compound | 0.95 |
| PIK3CA | involved_in | gene | 0.95 |
| PI3K Pathway Inhibitors | inhibits | drug | 0.95 |
| Polyphenols | targets | compound | 0.95 |
| Apigenin | inhibits | compound | 0.95 |
| Capivasertib | inhibits | drug | 0.92 |
| Alpelisib | inhibits | drug | 0.92 |
| MARCKS | activates | protein | 0.90 |
| insulin resistance | inhibits | phenotype | 0.90 |
| STX11 | inhibits | gene | 0.90 |
| PTEN | inhibits | protein | 0.90 |
| SPP1 | activates | protein | 0.90 |
| PTEN | inhibits | gene | 0.90 |
| Piperine | activates | compound | 0.90 |
| Sijunzi Decoction | targets | drug | 0.90 |
| Berberine | inhibits | compound | 0.90 |
| Fibroblast Autophagy | inhibits | process | 0.90 |
| PIK3CA | associated_with | gene | 0.90 |
| PTEN | regulates | gene | 0.90 |
| Pi3K Inhibitors | inhibits | drug | 0.90 |
| Akt Inhibitors | inhibits | drug | 0.90 |
| Mtor Inhibitors | inhibits | drug | 0.90 |
| MTOR | involved_in | gene | 0.88 |
| AKT1 | involved_in | gene | 0.88 |
| IRGM1 | activates | protein | 0.85 |
| KRAS | activates | gene | 0.85 |
| NOBILETIN | inhibits | compound | 0.80 |
| RAF/MEK/ERK Pathway | interacts_with | pathway | 0.75 |
| Gomisin N | activates | compound | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||